Menu

Cell Signaling in Cancer: New Targets, New Hope

The Scientist is bringing together a panel of experts to discuss their research and share insights into targeting these pathways with anti-cancer therapeutics.

May 31, 2017
The Scientist Creative Services Team

 

FREE Webinar

Thursday, June 1, 2017
2:30 - 4:00 P.M. EDT
Register Now

Communication between cancer cells has long been a target of drug-discovery efforts, but the conversations between cells can be convoluted and confused by signaling-pathway crosstalk, feedback loops, and other complex interactions. Recent advances have led to the elucidation of unexpected interactions between cells during the oncogenic transition, and these interactions are specific to the tumor microenvironment. To explore the advances in understanding cancer signaling, The Scientist is bringing together a panel of experts to discuss their research and share insights into targeting these pathways with anti-cancer therapeutics. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics related to their research.

Topics to be covered:

  • How the tumor microenvironment shapes tumor behavior and therapeutic efficacy
  • Signaling-pathway manipulation as a key strategy for anticancer therapies

Register Now

Meet the Speakers:

Lynne-Marie Postovit, PhD
Associate Professor, Department of Experimental Oncology
University of Alberta

 

 

 

 

William Weiss, MD, PhD
Professor, Departments of Neurology, Pediatrics, and Neurosurgery
University of California, San Francisco

 

 


 




July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.